Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 11, 2026

Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog

View original at globenewswire.com
Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog MISSISSAUGA, Ontario, March 11, 2026 (GLOBE NEWSWIRE) -- “In 2025, Bird successfully navigated near‑term revenue timing shifts while continuing to progress margins and strengthen the business…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The sole project for the customer with impaired receivables is substantially complete and no further costs are expected to be incurred

    60% confidence

  • Strong demand across key strategic sectors drove record combined backlog with accretive embedded margins, providing historic levels of forward visibility into revenue and earnings growth

    60% confidence

  • Bird remains strongly positioned for Canada's long-duration nation-building investment cycle, including large-scale capital investment energy projects such as LNG and nuclear, as well as infrastructure renewal across defence, healthcare, transportation and trade

    60% confidence

  • Bird successfully navigated near-term revenue timing shifts while continuing to progress margins and strengthen the business in 2025

    60% confidence

  • Bird's risk-balanced combined backlog reflects higher margins than a year ago, giving confidence in achieving growth and further profitability enhancement in 2026 and 2027

    60% confidence

  • Revenue for Q4 2025 was lower than 2024 driven by ongoing impact of previously disclosed delays in start of certain contracted projects

    60% confidence

  • With record liquidity and a strong balance sheet, Bird enters 2026 with flexibility, visibility, and momentum

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog — Source | Via News | ViaNews Market